Citadel Advisors
NRXS icon

Citadel Advisors’s Neuraxis NRXS Stock Holding History

Citadel Advisors’s Portfolio NRXS Stock Details NRXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$622K Buy
+85,053
New +$628K ﹤0.01% 9355
2025
Q4 		– Sell
-35,627
Closed -$110K – 13633
2025
Q3 		$110K Buy
35,627
+10,103
+40% +$25.7K ﹤0.01% 11784
2025
Q2 		$61.8K Sell
25,524
-1,297
-5% -$3.04K ﹤0.01% 11663
2025
Q1 		$57.7K Sell
26,821
-20,273
-43% -$48.9K ﹤0.01% 12158
2024
Q4 		$111K Buy
+47,094
New +$132K ﹤0.01% 11331
2024
Q3 		– Sell
-13,578
Closed -$37.7K – 14911
2024
Q2 		$37.7K Buy
+13,578
New +$41.4K ﹤0.01% 12040

Other funds holding NRXS

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCC
Money Concepts Capital Palm Beach Gardens, Florida $2.16B AUM 28.67% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
PC
Panoramic Capital Larkspur, California $232M AUM 255.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EPI
Eddie Patel Inc Chicago, Illinois $167M AUM

Citadel Advisors's NRXS Position: Q2 2026 in Review

Citadel Advisors opened a new position in Neuraxis (NRXS) in Q2 2026: 85,053 shares worth $622K. The stake represents ﹤0.01% of the portfolio and ranks #9355 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in NRXS as recently as Q3 2025.

Citadel Advisors first reported a position in NRXS in Q2 2024 and has held it in 6 quarters since. 32 funds tracked by Wall St. Rank hold NRXS as of Q2 2026.

  • Citadel Advisors held 85,053 shares of Neuraxis worth $622K as of Q2 2026.
  • Neuraxis was a new Citadel Advisors position in Q2 2026.
  • Neuraxis made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #9355 holding.
  • Citadel Advisors first reported a position in Neuraxis in Q2 2024 and has held it in 6 quarters since.
  • 32 funds tracked by Wall St. Rank held Neuraxis as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.